Mónica Furlano
banner
mfurlano.bsky.social
Mónica Furlano
@mfurlano.bsky.social
Nephrologist, Inherited kidney diseases working group, Rare kidney diseases, #GTERH @senefrologia.bsky.social
Reposted by Mónica Furlano
2️⃣ We used microscopic haematuria as an early flag, reaching out to families and offering genomic testing. Five kids + two family members diagnosed with Alport syndrome! 🩺 link.springer.com/article/10.1...
Cracking the code: an integrated electronic medical record approach to early diagnosis of genetic kidney disease in children with microscopic haematuria - Pediatric Nephrology
Background Microscopic haematuria (MH) is a common incidental finding in childhood that typically resolves spontaneously but, if persistent, can be a sign of underlying genetic kidney disease. Best pr...
link.springer.com
February 17, 2025 at 9:05 PM
Reposted by Mónica Furlano
-165 patients with #Alport syndrome enrolled
-Median duration of follow up was 90 weeks
-Sponsored by Regulus Therapeutics/Sanofi
-Results will be very useful for designing future interventional trials
March 8, 2025 at 4:08 PM
Reposted by Mónica Furlano
This initiative urges action to:
🔹 Improve global access to kidney care
🔹 Raise awareness of kidney health
🔹 Address environmental risks
🔹 Prioritize kidney diseases within the NCD agenda for stronger prevention and care.
Kidney disease and the global health agenda - International Society of Nephrology
theisn.org
March 4, 2025 at 5:23 PM
Reposted by Mónica Furlano
4️⃣ The KDIGO ADPKD Guideline offers a roadmap for evidence-based care, aiming to reduce the global burden of this inherited condition and improve lives worldwide.

Download the ADPKD Guideline, Executive Summary, and Data Supplement: kdigo.co/ADPKD

Read the guideline in KI: kdigo.co/ADPKD-Guidel...
January 21, 2025 at 3:24 PM